• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

用于治疗新型冠状病毒肺炎的草药医学与辨证论治：指南快速回顾

Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines.

作者信息

Ang Lin, Lee Hye Won, Choi Jun Yong, Zhang Junhua, Soo Lee Myeong

机构信息

Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.

Korean Convergence Medicine, University of Science and Technology, Daejeon, Republic of Korea.

出版信息

Integr Med Res. 2020 Jun;9(2):100407. doi: 10.1016/j.imr.2020.100407. Epub 2020 Mar 29.

DOI:10.1016/j.imr.2020.100407
PMID:32289016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7104236/
Abstract

BACKGROUND

Coronavirus disease 2019 (COVID-19) is pandemic and has caused illness to many people worldwide. This review aimed to summarize and analyze the herbal formulae provided by the guidelines for their pattern identifications (PIs) and compositions of herbs to treat patients with COVID-19.

METHODS

We searched 7 data sources for eligible traditional medicine guidelines up to March 6, 2020 and found a total of 28 traditional medicine guidelines that provide treatment measures for COVID-19.

RESULTS

Of the 28 guidelines, there were 26 government-issued Chinese guidelines and 2 Korean guidelines. After standardizing the terminology of the PIs and herbal formulae, there were 8 PIs and 23 herbal formulae for the mild stage, 11 PIs and 31 herbal formulae for the moderate stage, 8 PIs and 21 herbal formulae for the severe stage, and 6 PIs and 23 herbal formulae for the recovery stage in the Chinese guidelines. In the Korean guidelines, there were 4 PIs and 15 herbal formulae for the mild stage, 3 PIs and 3 herbal formulae for the severe stage, and 2 PIs and 2 herbal formulae for the recovery stage. In the frequency analysis of herbs, Glycyrrhizae Radix et Rhizoma was found to be the herb with the highest frequency of usage in the Chinese guidelines.

CONCLUSION

This review can be used as guidance for the traditional medicine treatment of COVID-19. Clinical evidence is needed in the future to evaluate the efficacy of traditional medicine.

摘要

背景

2019冠状病毒病（COVID-19）已大流行，在全球范围内致使众多人患病。本综述旨在总结并分析指南中针对COVID-19患者的证型辨识及草药配方。

方法

我们检索了7个数据源，以查找截至2020年3月6日符合条件的传统医学指南，共找到28份针对COVID-19提供治疗措施的传统医学指南。

结果

28份指南中，有26份是中国政府发布的指南，2份是韩国指南。在对证型辨识和草药配方的术语进行标准化后，中国指南中，轻症阶段有8种证型和23种草药配方，中症阶段有11种证型和31种草药配方，重症阶段有8种证型和21种草药配方，恢复期有6种证型和23种草药配方。韩国指南中，轻症阶段有4种证型和15种草药配方，重症阶段有3种证型和3种草药配方，恢复期有2种证型和2种草药配方。在草药使用频率分析中，发现甘草是中国指南中使用频率最高的草药。

结论

本综述可为COVID-19的传统医学治疗提供指导。未来需要临床证据来评估传统医学的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/118d/7153289/9c26532f3d6d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/118d/7153289/9c26532f3d6d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/118d/7153289/9c26532f3d6d/gr1.jpg

相似文献

1
Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines.用于治疗新型冠状病毒肺炎的草药医学与辨证论治：指南快速回顾
Integr Med Res. 2020 Jun;9(2):100407. doi: 10.1016/j.imr.2020.100407. Epub 2020 Mar 29.
2
Herbal medicine for treatment of children diagnosed with COVID-19: A review of guidelines.草药治疗 COVID-19 患儿：指南综述。
Complement Ther Clin Pract. 2020 May;39:101174. doi: 10.1016/j.ctcp.2020.101174. Epub 2020 Apr 12.
3
Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines.医学观察期内用于管理新型冠状病毒肺炎的草药医学：指南综述
Integr Med Res. 2020 Sep;9(3):100465. doi: 10.1016/j.imr.2020.100465. Epub 2020 Jul 1.
4
Network Analysis of Herbs Recommended for the Treatment of COVID-19.用于治疗新型冠状病毒肺炎的推荐草药的网络分析
Infect Drug Resist. 2021 May 18;14:1833-1844. doi: 10.2147/IDR.S305176. eCollection 2021.
5
Data mining and frequency analysis for licorice as a "Two-Face" herb in Chinese Formulae based on Chinese Formulae Database.基于中药方剂数据库的甘草作为中药方剂中“两面性”药物的数据挖掘与频次分析
Phytomedicine. 2014 Sep 25;21(11):1281-6. doi: 10.1016/j.phymed.2014.07.006. Epub 2014 Jul 31.
6
Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae.草药网络构建与共模块分析揭示中药方剂的组合规律。
BMC Bioinformatics. 2010 Dec 14;11 Suppl 11(Suppl 11):S6. doi: 10.1186/1471-2105-11-S11-S6.
7
[Treatment strategy and thought on classical herbal formulae for coronavirus disease 2019].[2019冠状病毒病经典方剂治疗策略与思路]
Zhongguo Zhong Yao Za Zhi. 2021 Jan;46(2):494-503. doi: 10.19540/j.cnki.cjcmm.20200603.501.
8
Study of the distribution patterns of the constituent herbs in classical Chinese medicine prescriptions treating respiratory disease by data mining methods.运用数据挖掘方法研究治疗呼吸疾病的中医经典方剂中药物的分布规律。
Chin J Integr Med. 2013 Aug;19(8):621-8. doi: 10.1007/s11655-012-1090-2. Epub 2012 May 19.
9
[Study on relevance mining of "core drug action target" in Dictionary of Traditional Chinese Medicine Prescriptions].[《中医方剂大辞典》中“核心药物作用靶点”关联挖掘研究]
Zhongguo Zhong Yao Za Zhi. 2018 Oct;43(19):3919-3926. doi: 10.19540/j.cnki.cjcmm.20180710.002.
10
Changes of Anti-tuberculosis Herbs Formula During Past Three Decades in Contrast to Ancient Ones.过去三十年抗结核草药方的变化与古代的对比。
Chin J Integr Med. 2021 May;27(5):388-393. doi: 10.1007/s11655-020-3475-y. Epub 2020 Jul 9.

引用本文的文献

1
Manuscript Title: Regulatory and Implications of Complementary and Alternative Medicine (CAM) Use for Infection Prevention: Insights From the Gulf Cooperation Council (GCC) Countries.稿件标题：补充和替代医学（CAM）用于感染预防的监管及影响：来自海湾合作委员会（GCC）国家的见解。
Risk Manag Healthc Policy. 2025 Jun 24;18:2081-2090. doi: 10.2147/RMHP.S522405. eCollection 2025.
2
Quercetin: A Flavonoid with Potential for Treating Acute Lung Injury.槲皮素：一种具有治疗急性肺损伤潜力的类黄酮。
Drug Des Devel Ther. 2024 Dec 6;18:5709-5728. doi: 10.2147/DDDT.S499037. eCollection 2024.
3
Taiwan Chingguan Yihau may improve post-COVID-19 respiratory complications through PI3K/AKT, HIF-1, and TNF signaling pathways revealed by network pharmacology analysis.

本文引用的文献

1
Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs.中医可否用于预防 2019 年冠状病毒病（COVID-19）？对历史经典、研究证据和当前预防方案的回顾。
Chin J Integr Med. 2020 Apr;26(4):243-250. doi: 10.1007/s11655-020-3192-6. Epub 2020 Feb 17.
2
Magnoflorine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Suppressing NF-κB and MAPK Activation.木兰碱通过抑制NF-κB和MAPK激活减轻脂多糖诱导的急性肺损伤。
Front Pharmacol. 2018 Aug 30;9:982. doi: 10.3389/fphar.2018.00982. eCollection 2018.
3
通过网络药理学分析揭示，台湾清冠一号可能通过PI3K/AKT、HIF-1和TNF信号通路改善新冠后呼吸并发症。
Mol Divers. 2025 Jun;29(3):2305-2321. doi: 10.1007/s11030-024-10993-8. Epub 2024 Oct 9.
4
Network pharmacology, molecular docking, and dynamics analyses to predict the antiviral activity of ginger constituents against coronavirus infection.网络药理学、分子对接和动力学分析预测姜的成分抗冠状病毒感染的抗病毒活性。
Sci Rep. 2024 May 27;14(1):12059. doi: 10.1038/s41598-024-60721-3.
5
The Role of Traditional Chinese Medicine and Chinese Pharmacopoeia in the Evaluation and Treatment of COVID-19.中医药和《中国药典》在评估和治疗 COVID-19 中的作用。
Curr Pharm Des. 2024;30(14):1060-1074. doi: 10.2174/0113816128217263240220060252.
6
Green algae compounds as antiviral candidates for SARS-CoV-2: In silico study.绿藻化合物作为新型冠状病毒肺炎的抗病毒候选物：计算机模拟研究
Narra J. 2023 Aug;3(2):e179. doi: 10.52225/narra.v3i2.179. Epub 2023 Jul 26.
7
A natural product YSK-A blocks SARS-CoV-2 propagation by targeting multiple host genes.天然产物 YSK-A 通过靶向多个宿主基因来阻断 SARS-CoV-2 的传播。
Sci Rep. 2023 Dec 6;13(1):21489. doi: 10.1038/s41598-023-48854-3.
8
Plant-Derived Antioxidants for Management of COVID-19: A Comprehensive Review of Molecular Mechanisms.用于管理新冠病毒病的植物源性抗氧化剂：分子机制的全面综述
Tanaffos. 2023 Jan;22(1):27-39.
9
Efficacy of topical galbanum oil with dry cupping in hospitalized COVID-19 patients: A randomized open-label clinical trial.住院新冠肺炎患者外用白松香精油结合闪罐疗法的疗效：一项随机开放标签临床试验。
Avicenna J Phytomed. 2023 Jul-Aug;13(4):388-399. doi: 10.22038/AJP.2023.21829.
10
Medicinal plant sources and traditional healthcare practices of forest-dependent communities in and around Chunati Wildlife Sanctuary in southeastern Bangladesh.孟加拉国东南部Chunati野生动物保护区及其周边地区依赖森林的社区的药用植物来源和传统医疗实践。
Environ Sustain (Singap). 2022;5(2):207-241. doi: 10.1007/s42398-022-00230-z. Epub 2022 Jun 7.
Protective Effects of Platycodin D on Lipopolysaccharide-Induced Acute Lung Injury by Activating LXRα-ABCA1 Signaling Pathway.
桔梗皂苷D通过激活肝X受体α-ATP结合盒转运蛋白A1信号通路对脂多糖诱导的急性肺损伤的保护作用
Front Immunol. 2017 Jan 3;7:644. doi: 10.3389/fimmu.2016.00644. eCollection 2016.
4
Pharmacokinetics of aconitine-type alkaloids after oral administration of Fuzi (Aconiti Lateralis Radix Praeparata) in rats with chronic heart failure by microdialysis and ultra-high performance liquid chromatography-tandem mass spectrometry.采用微透析和超高效液相色谱-串联质谱法研究附子（制附子）口服给药后慢性心力衰竭大鼠中乌头碱型生物碱的药代动力学
J Ethnopharmacol. 2015 May 13;165:173-9. doi: 10.1016/j.jep.2015.01.057. Epub 2015 Feb 20.
5
[Study on in vitro anti-inflammatory activity of total flavonoids from Glycyrrhizae Radix et Rhizoma and its ingredients].甘草总黄酮及其成分的体外抗炎活性研究
Zhongguo Zhong Yao Za Zhi. 2013 Jan;38(1):99-104.
6
Pharmacological effects of Chinese herb aconite (fuzi) on cardiovascular system.中药附子（fuzi）对心血管系统的药理作用。
J Tradit Chin Med. 2012 Sep;32(3):308-13. doi: 10.1016/s0254-6272(13)60030-8.
7
Traditional Chinese herbal medicine as a source of molecules with antiviral activity.传统中药作为具有抗病毒活性的分子来源。
Antiviral Res. 2013 Jan;97(1):1-9. doi: 10.1016/j.antiviral.2012.10.006. Epub 2012 Nov 12.
8
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.10株严重急性呼吸综合征冠状病毒临床分离株对所选抗病毒化合物的体外敏感性
J Clin Virol. 2004 Sep;31(1):69-75. doi: 10.1016/j.jcv.2004.03.003.